Richard Park

Title: Richard Park: Innovator in Tumor Treatment

Introduction

Richard Park is an accomplished inventor based in Baltimore, MD (US). He has made significant contributions to the field of medical treatments, particularly in the area of tumor therapy. His innovative approach focuses on the delivery of catecholic butanes, which has the potential to improve treatment outcomes for patients with tumors and other proliferative diseases.

Latest Patents

Richard Park holds a patent for "Methods for delivery of catecholic butanes for treatment of tumors." This invention provides kits, methods, and compositions designed for the treatment of tumors and similar diseases. The compositions include a substantially pure preparation of at least one catecholic butane, such as NDGA compounds, combined with a pharmaceutically acceptable carrier or excipient. The administration of these compounds is done through routes other than direct injection into affected tissues or topical application, offering a novel approach to treatment.

Career Highlights

Throughout his career, Richard Park has worked with notable organizations, including Erimos Pharmaceuticals and The Johns Hopkins University. His work in these institutions has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research in tumor treatment.

Collaborations

Richard has collaborated with esteemed colleagues such as Ru Chih C Huang and Chih-Chuan Chang. These partnerships have further enhanced his research and development efforts in the medical field.

Conclusion

Richard Park's innovative work in the treatment of tumors through the delivery of catecholic butanes showcases his dedication to advancing medical science. His contributions have the potential to significantly impact patient care and treatment methodologies.